Epigenetic aspects in rehabilitation of female cancer patients
Open Access
- 28 July 2022
- journal article
- research article
- Published by IRBIS in FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
- Vol. 15 (2) , 294-303
Abstract
The influence of epigenetic processes on the development of malignant diseases, including gynaecological cancers, is now beyond doubt. DNA methylation, histone modification and post-transcriptional regulation by microRNAs lead to changes in the activity of various genes, contributing to female genital cancers (cervix, endometrium, ovarian). It should be noted that disruptions in gene expression do not only occur in malignant cells, but also in the tumour microenvironment, resulting in disease progression and relapse. However, “epigenetic markers” of carcinogenesis can be useful in the treatment and rehabilitation of patients, making a personalized approach possible.Keywords
This publication has 45 references indexed in Scilit:
- Epigenetics in ovarian cancerSeminars in Cancer Biology, 2018
- Signaling coupled epigenomic regulation of gene expressionOncogene, 2017
- Pathogenesis and heterogeneity of ovarian cancerCurrent Opinion in Obstetrics and Gynecology, 2017
- Therapeutic perspectives of epigenetically active nutrientsBritish Journal of Pharmacology, 2014
- Melatonin, Noncoding RNAs, Messenger RNA Stability and Epigenetics—Evidence, Hints, Gaps and PerspectivesInternational Journal of Molecular Sciences, 2014
- Epigenetic biomarkers in epithelial ovarian cancerCancer Letters, 2014
- Epigenetics in Ovarian Cancer2012
- Long-Term Consequences of Chronic Pain: Mounting Evidence for Pain as a Neurological Disease and Parallels with Other Chronic Disease StatesPain Medicine, 2011
- Epigenetics and LifestyleEpigenomics, 2011
- Epigenetics of ovarian cancer: From the lab to the clinicGynecologic Oncology, 2010